Profile
Full Name
SAB Biotherapeutics, Inc.Ticker Symbol
SABSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 9, 2021Indexes
Not includedEmployees
63Key Details
Price
$1.23(+4.24%)
Market cap
$11.35M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.68(+51.83% YoY)
PE ratio
-
Next earnings date
May 20, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
SAB Biotherapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 1, 25 HC Wainwright & Co.
BuyApr 1, 25 Chardan Capital
BuyJan 29, 25 HC Wainwright & Co.
BuyJan 29, 25 Chardan Capital
BuyNov 7, 24 Chardan Capital
BuyOct 9, 24 Craig-Hallum
BuySep 12, 24 Oppenheimer
OutperformSep 9, 24 Chardan Capital
BuyAug 28, 24 Oppenheimer
OutperformAug 12, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for SAB Biotherapeutics?
- Does SAB Biotherapeutics pay dividends?
- What sector is SAB Biotherapeutics in?
- What industry is SAB Biotherapeutics in?
- What country is SAB Biotherapeutics based in?
- When did SAB Biotherapeutics go public?
- Is SAB Biotherapeutics in the S&P 500?
- Is SAB Biotherapeutics in the NASDAQ 100?
- Is SAB Biotherapeutics in the Dow Jones?
- When was SAB Biotherapeutics's last earnings report?
- When does SAB Biotherapeutics report earnings?
- Should I buy SAB Biotherapeutics stock now?
What is the ticker symbol for SAB Biotherapeutics?
The ticker symbol for SAB Biotherapeutics is NASDAQ:SABS
Does SAB Biotherapeutics pay dividends?
No, SAB Biotherapeutics does not pay dividends
What sector is SAB Biotherapeutics in?
SAB Biotherapeutics is in the Healthcare sector
What industry is SAB Biotherapeutics in?
SAB Biotherapeutics is in the Biotechnology industry
What country is SAB Biotherapeutics based in?
SAB Biotherapeutics is headquartered in United States
When did SAB Biotherapeutics go public?
SAB Biotherapeutics's initial public offering (IPO) was on February 9, 2021
Is SAB Biotherapeutics in the S&P 500?
No, SAB Biotherapeutics is not included in the S&P 500 index
Is SAB Biotherapeutics in the NASDAQ 100?
No, SAB Biotherapeutics is not included in the NASDAQ 100 index
Is SAB Biotherapeutics in the Dow Jones?
No, SAB Biotherapeutics is not included in the Dow Jones index
When was SAB Biotherapeutics's last earnings report?
SAB Biotherapeutics's most recent earnings report was on Mar 31, 2025
When does SAB Biotherapeutics report earnings?
The next expected earnings date for SAB Biotherapeutics is May 20, 2025
Should I buy SAB Biotherapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions